Headlands Technologies LLC purchased a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 6,841 shares of the company’s stock, valued at approximately $687,000.
Several other hedge funds and other institutional investors have also bought and sold shares of the business. Oregon Public Employees Retirement Fund grew its stake in Addus HomeCare by 2.5% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock valued at $446,000 after purchasing an additional 103 shares during the period. ProShare Advisors LLC increased its position in shares of Addus HomeCare by 3.1% during the 4th quarter. ProShare Advisors LLC now owns 3,527 shares of the company’s stock valued at $379,000 after purchasing an additional 105 shares during the last quarter. CANADA LIFE ASSURANCE Co raised its stake in shares of Addus HomeCare by 0.6% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock worth $2,150,000 after purchasing an additional 106 shares during the period. State of Wyoming raised its stake in shares of Addus HomeCare by 25.7% during the 4th quarter. State of Wyoming now owns 523 shares of the company’s stock worth $56,000 after purchasing an additional 107 shares during the period. Finally, Pathstone Holdings LLC boosted its holdings in shares of Addus HomeCare by 0.9% in the 3rd quarter. Pathstone Holdings LLC now owns 12,727 shares of the company’s stock worth $1,502,000 after buying an additional 112 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on ADUS shares. Barclays increased their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research report on Wednesday, July 8th. Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Citizens Jmp reissued a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. Citigroup reissued a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. Finally, Royal Bank Of Canada raised their price target on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $128.86.
Insider Buying and Selling at Addus HomeCare
In other news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by insiders.
Addus HomeCare Stock Up 3.2%
ADUS stock opened at $118.17 on Thursday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. The company has a market capitalization of $2.21 billion, a price-to-earnings ratio of 20.73, a PEG ratio of 1.54 and a beta of 0.86. Addus HomeCare Corporation has a fifty-two week low of $87.95 and a fifty-two week high of $124.43. The stock has a fifty day moving average of $113.14 and a 200-day moving average of $103.06.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The company had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. During the same quarter last year, the firm posted $1.49 EPS. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. As a group, equities research analysts predict that Addus HomeCare Corporation will post 6.3 earnings per share for the current year.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Stories
- Five stocks we like better than Addus HomeCare
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
